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CASE BASED DISCUSSION
Metalworking ﬂuids: a new cause of occupational
non-asthmatic eosinophilic bronchitis
R E Wiggans,1,2 C M Barber2,3
Ruth E Wiggans (REW): A 52-year-old man was
referred with chronic cough of increasing severity
over the last 4 years. The cough was productive of
green sputum and he experienced coughing attacks
weekly. He reported no other respiratory symp-
toms. He had a sore throat following coughing
bouts but denied other upper airway complaints.
He was otherwise well with no systemic symptoms.
His cough had improved following a 2-week
summer holiday, and subsequently deteriorated fol-
lowing his return to work.
A chest X-ray organised in primary care was
normal. Three years earlier, his general practitioner
increased his lansoprazole from 15 to 30 mg once
daily for cough. This had not helped although
treatment continued. His past medical history
included treated obstructive sleep apnoea and
hypertension for which he took bendroﬂumethia-
zide and losartan; the latter substituted for his ACE
inhibitor 3 years earlier. He recalled no personal or
family history of asthma or atopy and was a lifelong
non-smoker. He had kept budgerigars until
6 months previously when the last bird died.
He had worked for 12 years as a computer
numerical control (CNC) machine setter and oper-
ator, machining metal parts used to make tools for
woodworking. He machined bronze, brass, leaded
mild steel, high-speed steel and aluminium pieces
to the desired speciﬁcation. He operated ﬁve
machines in a single area of the factory, adjacent to
where ash handles were turned. He was the sole
CNC operator turning metal components in the
factory and was not aware of any colleagues report-
ing respiratory symptoms.
Water-based metalworking ﬂuids (MWFs) were
used on all ﬁve machines. Each machine collected
and recirculated MWFs via its own sump. For the
last 4 years, the ﬂuids had occasionally become
‘foul smelling’ and sometimes changed colour from
a translucent blue to a chocolate brown. The work-
site did not perform dip-slide ﬂuid analysis or use
biocide contrary to agreed industry practice. The
patient reported exposure to MWF mist when
opening the machine doors and cleaning with com-
pressed air. He wore a non-ﬁt tested disposable
paper mask for respiratory protective equipment.
Physical examination of the patient was normal.
Spirometry revealed an FEV1 of 3.17 L (83% pre-
dicted), FVC of 3.9 L (81%) and a FEV1/FVC ratio
of 104%. FENO was 92 parts per billion (ppb).
TLCO was 12.4 (116%) mmol/min/kPa and KCO
2.29 (160%) mmol/min/kPa/L. Total IgE was raised
at 122 KU/L, peripheral eosinophils normal at
0.13×109/L and speciﬁc IgG to aspergillus,
budgerigar and pigeon within normal limits. A high
resolution CT (HRCT) performed midway through
a normal working week revealed mild gas trapping
on expiratory views.
Chris M Barber (CMB): A priority in this case is to
understand whether the cough is being aggravated
by a workplace exposure, or is a symptom of an
occupational lung disease. This distinction is
important as occupational conditions commonly
deteriorate with ongoing exposure to the offending
agent, and prognosis is better with early recogni-
tion and exposure modiﬁcation. An accurate diag-
nosis is important to avoid unnecessary change in a
patient’s work. In addition, any diagnosis of an
occupational lung disease has potential implications
for other exposed workers who are also at risk.
His exposure to MWFs is highly relevant. They
are a common cause of occupational asthma (OA)
in Britain and the leading cause of occupational
extrinsic allergic alveolitis (EAA).1 Occupational
respiratory diseases associated with water-
containing MWFs have increased in incidence since
MWFs have widely replaced neat oil coolants. Used
MWFs are recirculated via stand-alone or
shared-sump reservoirs, with those containing
water at risk of microbial contamination. These
microbes and their constituents are aerosolised in
MWF mist, which workers may then inhale. In
addition to bioaerosols, previous challenge studies
have established chemical constituents of MWFs
including ethanolamine and biocides to be causes
of OA.2 Metals dissolved in MWFs have also been
reported to cause asthma, but none used in this
case were known causes. Thus, although exact
mechanisms are not fully understood, inhalation of
both chemical and biological allergens in MWF
mist is thought to cause OA in susceptible workers.
MWF-related occupational lung diseases may
occur in outbreaks. Such outbreaks are logistically
challenging to manage, as although hundreds of
workers may report work-related symptoms, the
majority do not have an occupational disease.
Work-related cough has been common among past
outbreaks, being attributed to conditions including
EAA, OA, work-aggravated asthma, bronchitis and
rhinitis. The cause of MWF-related disease can be
difﬁcult to ascertain, as exposures may have
changed before a worker is assessed, for example
by relocation to another area or indeed if an indi-
vidual loses their job. It is vital to obtain a detailed
history from patients to understand as precisely as
possible the timing of their symptoms, their rela-
tionship with work, the details of their working
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environment and exposures, and the implications of a change in
work circumstances.
His work-related cough and high FENO suggests work-related
asthma. An OASYS serial peak ﬂow analysis was requested to
examine this further. OASYS measurements are typically made
over a period of 3–4 weeks, and any change in working prac-
tices or medication over this time may affect the results.
Decisions delaying treatment are made on a case-by-case basis,
being determined by the symptoms and stability of the patient.
REW: Two months later, his OASYS demonstrated minimal
diurnal variation (DV) at and away from work (5.6% and 6.5%,
respectively), with a maximal DV of 13%. The work-effect
index (WEI) was negative at 1.64. As the WEI was negative but
DV borderline, a mannitol challenge was requested to look for
further evidence of airway hyperresponsiveness.
The test was performed during a routine working week on no
inhaled corticosteroids (ICS). The maximum % change in FEV1
was 2.8 following the complete dose of 635 mg osmohale, with
a maximum FEV1 change between doses of −1.4%. A repeat
FENO taken midway through the working week was 94 ppb. An
induced sputum sample done at the same time contained 14%
eosinophils. Occupational eosinophilic bronchitis was suspected,
and the patient returned following a week off work for a repeat
FENO. At this point, FENO had dropped to 11 ppb. A diagnosis
of occupational non-asthmatic eosinophilic bronchitis (NAEB)
was made and the patient commenced on ICS. He was provided
with written conﬁrmation of the diagnosis and recommenda-
tions about how to reduce further MWF exposures. Work pro-
vided ﬁt-tested half-face disposable masks and the patient
reduced his use of compressed air. At his next appointment, a
midweek FENO on ICS was 18 ppb and his cough had almost
disappeared.
CMB: In the absence of signiﬁcant peak expiratory ﬂow rate
(PEFR) variation, DV and measurable airway responsiveness
classical asthma is unlikely. The WEI is negative, suggesting
work-related changes in airway calibre do not explain his symp-
toms. EAA is also unlikely to be the cause of his cough, given
his HRCT and lung function. In the absence of classical asthma,
the very high FENO and sputum eosinophilia are suggestive of
NAEB. The work-related change in FENO conﬁrms that this is
occupational NAEB, further reinforced by the response to
inhaled steroid and reduced exposure.
To our knowledge, this is the ﬁrst case of NAEB caused by
MWF exposure. NAEB is deﬁned as a chronic productive cough
without symptomatic or physiological evidence of variable
airﬂow obstruction, normal airway responsiveness and sputum
eosinophilia >3%. It accounts for between 10% and 30% of
cases of chronic cough referred for specialist assessment and
tends to be more common in non-smokers. The condition has
been reported to have been caused by a small number of occu-
pational agents also recognised to cause OA including acrylates,
isocyanates, ﬂour, α amylase, chloramine, styrene, formalde-
hyde, latex and stainless steel welding.3 Since a number of
agents present in MWFs can cause OA, it is plausible that they
cause NAEB.
Asthma and NAEB share common pathological features. High
levels of eosinophils have been observed in sputum, bronchoal-
veolar lavage and biopsy in both conditions. However, NAEB is
associated with increased superﬁcial airway mast cell inﬁltration,
unlike the smooth muscle inﬁltration associated with asthma.
This superﬁcial airway inﬁltration may explain the prominence
of cough in NAEB and the absence of airway remodelling and
hyperresponsiveness.4 Furthermore, this superﬁcial airway inﬁl-
tration and subsequent inﬂammation may expose afferent nerve
ﬁbres involved in the cough reﬂex, increasing symptoms and
aggravating the inﬂammatory response.
There are no long-term follow-up studies investigating out-
comes in occupational NAEB. Evidence from the few follow-up
studies in non-occupational NAEB suggests that over two-thirds
of affected individuals continue to be symptomatic 1 year after
diagnosis, with around 10% going on to develop more classical
features of asthma.5 For this patient, removal from exposures
would be ideal to present the best outcome for symptom
control. Unfortunately, relocation is not always possible as
employment opportunities carrying the same skill level,
payment and job satisfaction may not be available. Though
employers have a responsibility to relocate workers wherever
possible, they are not always able or willing to do this.
Occupational NAEB should be considered in patients with
chronic cough who work with fumes, dusts, gases or vapours,
particularly if the cough improves on rest days or holidays.
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